Research ArticleOMERACT 10: 10th International Consensus Conference on Outcome Measures in Rheumatology, Kota Kinabalu, Borneo - May 4–8, 2010

OMERACT 10 Sharp Symposium: Important Findings in Examination of Imaging Methods for Measurement of Joint Damage in Rheumatoid Arthritis

VIBEKE STRAND, SARAH R. KINGSBURY, THASIA WOODWORTH, ROBERT LANDEWÉ, MIKKEL ØSTERGAARD, CHARLES PETERFY, DÉSIRÉE van der HEIJDE, MARIA-ANTONIETTA D’AGOSTINO, WALTER MAKSYMOWYCH, PAUL P. TAK, GEORGE WELLS and PHILIP G. CONAGHAN
The Journal of Rheumatology September 2011, 38 (9) 2009-2013; DOI: https://doi.org/10.3899/jrheum.110415

REFERENCES

  1. 1.↵
    1. Strand V,
    2. Sharp J
    . Radiographic data from recent randomized controlled trials in rheumatoid arthritis: What have we learned? Arthritis Rheum 2003;48:21–34.
    OpenUrlCrossRefPubMed
  2. 2.↵
    1. van der Heijde D,
    2. Landewe R,
    3. Sharp JT
    . Repair in rheumatoid arthritis, current status. Report of a workshop at OMERACT 8. J Rheumatol 2007;34:884–8.
    OpenUrlAbstract/FREE Full Text
  3. 3.↵
    1. Sharp JT,
    2. Angwin J,
    3. Boers M,
    4. Duryea J,
    5. Finckh A,
    6. Hall JR,
    7. et al.
    Multiple computer-based methods of measuring JSW can discriminate between treatment arms in the COBRA Trial — update of an ongoing OMERACT project. J Rheumatol 2009;36:1825–8.
    OpenUrlAbstract/FREE Full Text
  4. 4.↵
    1. Sharp JT,
    2. Lidsky MD,
    3. Collins LC,
    4. Moreland J
    . Methods of scoring the progression of radiologic changes in rheumatoid arthritis: correlation of radiologic, clinical and laboratory abnormalities. Arthritis Rheum 1971;14:706–20.
    OpenUrlPubMed
  5. 5.↵
    1. van der Heijde D
    . How to read radiographs according to the Sharp/van der Heijde method. J Rheumatol 2000;27:261–3.
    OpenUrlPubMed
  6. 6.↵
    1. Genant GK,
    2. Jiang Y,
    3. Peterfy C,
    4. Lu Y,
    5. Reidei Y,
    6. Countryman P
    . Assessment of rheumatoid arthritis using a modified scoring method on digitized and original radiographs. Arthritis Rheum 1998;40:1583–90.
    OpenUrl
  7. 7.↵
    1. Jamal S,
    2. Patra K,
    3. Keystone EC
    . Adalimumab response in patients with early versus established rheumatoid arthritis: DE019 randomized controlled trial subanalysis. Clin Rheumatol 2009;28:413–9.
    OpenUrlCrossRefPubMed
  8. 8.↵
    1. Genant HK,
    2. Peterfy CG,
    3. Westhovens R,
    4. Becker JC,
    5. Aranda R,
    6. Vratsanos G,
    7. et al.
    Abatacept inhibits progression of structural damage in rheumatoid arthritis: results from the long-term extension of the AIM trial. Ann Rheum Dis 2008;67:1084–9.
    OpenUrlAbstract/FREE Full Text
  9. 9.↵
    1. Keystone E,
    2. Heijde D,
    3. Mason D Jr.,
    4. Landewe R,
    5. Vollenhoven RV,
    6. Combe B,
    7. et al.
    Certolizumab pegol plus methotrexate is significantly more effective than placebo plus methotrexate in active rheumatoid arthritis: findings of a fifty-two-week, phase III, multicenter, randomized, double-blind, placebo-controlled, parallel-group study. Arthritis Rheum 2008;58:3319–29.
    OpenUrlCrossRefPubMed
  10. 10.↵
    1. Smolen J,
    2. Landewe RB,
    3. Mease P,
    4. Brzezicki J,
    5. Mason D,
    6. Luijtens K,
    7. et al.
    Efficacy and safety of certolizumab pegol plus methotrexate in active rheumatoid arthritis: the RAPID 2 study. A randomised controlled trial. Ann Rheum Dis 2009;68:797–804.
    OpenUrlAbstract/FREE Full Text
  11. 11.↵
    1. Klareskog L,
    2. van der Heijde D,
    3. de Jager JP,
    4. Gough A,
    5. Kalden J,
    6. Malaise M,
    7. et al.
    Therapeutic effect of the combination of etanercept and methotrexate compared with each treatment alone in patients with rheumatoid arthritis: double-blind randomised controlled trial. Lancet 2004;363:675–81.
    OpenUrlCrossRefPubMed
  12. 12.↵
    1. Emery P,
    2. Breedveld FC,
    3. Hall S,
    4. Durez P,
    5. Chang DJ,
    6. Robertson D,
    7. et al.
    Comparison of methotrexate monotherapy with a combination of methotrexate and etanercept in active, early, moderate to severe rheumatoid arthritis (COMET): a randomised, double-blind, parallel treatment trial. Lancet 2008;372:375–82.
    OpenUrlCrossRefPubMed
  13. 13.↵
    1. Landewé RBM,
    2. Strand V,
    3. Conaghan PG,
    4. van der Heijde DM
    . Damage and progression on radiographs in individual joints: data from pivotal randomized controlled trials. J Rheumatol 2011;38:2018–22.
    OpenUrlAbstract/FREE Full Text
  14. 14.↵
    1. Peterfy CG,
    2. Countryman P,
    3. Gabriele A,
    4. Shaw T,
    5. Anisfeld A,
    6. Tsuji W,
    7. et al.
    MRI in RA clinical trials: Emerging patterns based on recent experience. J Rheumatol 2011;38:2023–31.
    OpenUrlAbstract/FREE Full Text
  15. 15.↵
    1. McQueen FM
    . A vital clue to deciphering bone pathology: MRI bone oedema in rheumatoid arthritis and osteoarthritis. Ann Rheum Dis 2007;66:1549–52.
    OpenUrlFREE Full Text
  16. 16.↵
    1. Jimenez-Boj E,
    2. Nöbauer-Huhmann I,
    3. Hanslik-Schnabel B,
    4. Dorotka R,
    5. Wanivenhaus AH,
    6. Kainberger F,
    7. et al.
    Bone erosions and bone marrow edema as defined by magnetic resonance imaging reflects true bone marrow inflammation in rheumatoid arthritis. Arthritis Rheum 2007;56:1118–24.
    OpenUrlCrossRefPubMed
  17. 17.↵
    1. Hetland ML,
    2. Ejbjerg B,
    3. Hørslev-Petersen K,
    4. Jacobsen S,
    5. Vestergaard A,
    6. Jurik AG,
    7. et al.
    MRI bone oedema is the strongest predictor of subsequent radiographic progression in early rheumatoid arthritis. Results from a 2-year randomised controlled trial (CIMESTRA). Ann Rheum Dis 2009;68:384–90.
    OpenUrlAbstract/FREE Full Text
  18. 18.↵
    1. Ostergaard M,
    2. Dohn UM,
    3. Duer-Jensen A,
    4. Hetland ML,
    5. Herslev-Petersen K,
    6. Stengaard-Petersen K,
    7. et al.
    Patterns of MRI bone erosion in rheumatoid arthritis — which bones are most frequently involved and show the most change? J Rheumatol 2011;38:2014–7.
    OpenUrlAbstract/FREE Full Text
  19. 19.↵
    1. Mandl P,
    2. Naredo E,
    3. Wakefield RJ,
    4. Conaghan PG,
    5. D’Agostino MA
    . A systematic literature review analysis of ultrasound joint count and scoring systems to assess synovitis in rheumatoid arthritis, according to the OMERACT filter. J Rheumatol 2011;38:2055–62.
    OpenUrlAbstract/FREE Full Text
  20. 20.↵
    1. van de Sande MG,
    2. Gerlag DM,
    3. Lodde BM,
    4. van Baarsen LG,
    5. Alivernini S,
    6. Codullo V,
    7. et al.
    Evaluating antirheumatic treatments using synovial biopsy: a recommendation for standardisation to be used in clinical trials. Ann Rheum Dis 2011;70:423–7.
    OpenUrlAbstract/FREE Full Text
Back to top

In this issue

Print
Download PDF
Article Alerts
Email Article
Citation Tools

 Request Permissions

Bookmark this article

Jump to section